Research Associate, Division of Evidence Synthesis, Global Evidence Synthesis Initative (GESI), Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, 442001, India.
Professor and Head, i-Health Consortium, Department of Biochemistry, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, 442004, India.
F1000Res. 2024 Feb 5;12:297. doi: 10.12688/f1000research.131768.2. eCollection 2023.
Tuberculosis (TB) is among the deadliest diseases and a significant cause of illnessacross the globe. Several studies on mycobacterial proteins, such as proteases and transporters that are essential for survival and pathogenesis have aimed to develop an efficient anti-tubercular agent. In mycobacterium, lysine exporter (LysE) is an amino acid transporter and a probable target for an anti-tubercular agent as it is responsible for bacterial growth inhibition and is also absent in the widely used Bacillus Calmette-Guérin (BCG) vaccine.
Some studies have purified LysE using different protocols. This study describes a protocol for purifying different constructs of LysE, focusing on its hydrophobic region using immobilized metal affinity chromatography (IMAC) after expressing LysE gene in a bacterial expression system. pET vector (pET28a) is used as an expression vector. Amplified LysE gene is ligated with the pET28a vector, and the resultant plasmid is then transformed into E. coli cells. The vector has a histidine tag that makes the purification process convenient. After IMAC, the samples will be subjected to size-exclusion chromatography for further purification.
Cloning and amplification findings will be analyzed using 1% agarose gel, and protein expression and purification outcomes will be examined using sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Domain-specific constructs of LysE can be further analyzed as an anti-tubercular agent.
Despite being a potential anti-tubercular target, research is quite limited on this protein. Therefore, we aim to purify LysE protein for further analysis. Similar protocols have already been implemented to purify several other bacterial proteins with >95% purity.
结核病(TB)是最致命的疾病之一,也是全球范围内疾病的主要病因。许多关于分枝杆菌蛋白的研究,如蛋白酶和转运蛋白,这些蛋白对生存和发病机制至关重要,旨在开发有效的抗结核药物。在分枝杆菌中,赖氨酸外排蛋白(LysE)是一种氨基酸转运蛋白,可能是抗结核药物的靶点,因为它负责细菌生长抑制,并且在广泛使用的卡介苗(BCG)疫苗中不存在。
一些研究使用不同的方案来纯化 LysE。本研究描述了一种使用固定化金属亲和层析(IMAC)纯化不同 LysE 构建体的方案,重点是在细菌表达系统中表达 LysE 基因后对其疏水区进行纯化。pET 载体(pET28a)用作表达载体。扩增的 LysE 基因与 pET28a 载体连接,然后将所得质粒转化到大肠杆菌细胞中。该载体具有组氨酸标签,使纯化过程更加方便。在 IMAC 之后,样品将进行分子筛层析以进一步纯化。
克隆和扩增结果将使用 1%琼脂糖凝胶进行分析,蛋白表达和纯化结果将使用十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)进行检查。LysE 的结构域特异性构建体可进一步分析作为抗结核药物。
尽管作为一种潜在的抗结核靶点,但对该蛋白的研究相当有限。因此,我们旨在纯化 LysE 蛋白以进行进一步分析。类似的方案已经用于纯化其他几种具有>95%纯度的细菌蛋白。